DILLON? >> THAT REP TELLING LAWYERS OVER AND OVE AGAIN WHAT SHE SAID TO DOCTORS HERE IN OKLAHOMA AND ON TOP OF THAT, SHE SAID OVER AND OVER THAT SHE DIDN’T REMEMBER WHAT JOHNSON AND JOHNSON TAUGHT HER ABOUT MARKETING OPIOIDS TO DOCTORS SINCE SHE HASN’T SOLD THE DRUGS FOR YEARS. THE STATE TRYING TO PROVE THAT SALES REPS MISREPRESENTED DRUGS TO DOCTORS, ARGUING THAT THEY WERE GIVEN A HIGHER BONUES IF DOCTOR STARTED WRITING MORE PRESCRIPTIONS AFTER VISITING. >> SO THEY TOLD YOU WHAT TO AND NOT TO SAY? >> WELL, WE JUST WE WERE TRAINED ON WHAT WE COULD TALK ABOUT AND WHAT WE’RE NOT ABLE TO TALK AB,OUT. SO WHAT WAS APPROVED. BY THE COMPANY AND WHAT ALIGNED WITH THE FDA. >> SO YOU DID WHAT YOU WERE TOLD BY YOUR EMPLOYER. >> I DID WHAT I WAS TOLD. >> WE EXPECT THE DEFENSE TO CONTINUE THEIR CASE TOMORROW, ARGUING THAT J&J ACT
Judge denies motion to end case against drugmaker in Oklahoma opioid trial
![KOCO logo]()
Updated: 12:34 PM CDT Jul 8, 2019
An Oklahoma judge says the state's ongoing opioid drug lawsuit against consumer products giant Johnson & Johnson can move forward.District Judge Thad Balkman on Monday denied a motion from the defendant's lawyers asking him to end Oklahoma's public-nuisance lawsuit and rule in favor of the New Brunswick, New Jersey-based company and its subsidiaries. The defendants filed the motion last week after the state rested its case. The trial began May 28.Company attorneys argued the state's case is an inappropriate use of a public-nuisance claim , typically reserved for disputes over property.Oklahoma says the company helped fuel the opioid crisis in Oklahoma with an aggressive marketing campaign that overstated the effectiveness and understated the addiction risk of opioids. The state wants the company to pay to help alleviate the opioid crisis.
OKLAHOMA CITY — An Oklahoma judge says the state's ongoing opioid drug lawsuit against consumer products giant Johnson & Johnson can move forward.
District Judge Thad Balkman on Monday denied a motion from the defendant's lawyers asking him to end Oklahoma's public-nuisance lawsuit and rule in favor of the New Brunswick, New Jersey-based company and its subsidiaries. The defendants filed the motion last week after the state rested its case. The trial began May 28.
Company attorneys argued the state's case is an inappropriate use of a public-nuisance claim , typically reserved for disputes over property.
Oklahoma says the company helped fuel the opioid crisis in Oklahoma with an aggressive marketing campaign that overstated the effectiveness and understated the addiction risk of opioids. The state wants the company to pay to help alleviate the opioid crisis.
